nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Tamoxifen—pancreatic cancer	0.101	0.186	CbGbCtD
Argatroban—CYP3A5—Erlotinib—pancreatic cancer	0.0857	0.159	CbGbCtD
Argatroban—CYP3A5—Irinotecan—pancreatic cancer	0.0774	0.143	CbGbCtD
Argatroban—F2—hepatic artery—pancreatic cancer	0.0688	0.458	CbGeAlD
Argatroban—F2—portal vein—pancreatic cancer	0.0597	0.397	CbGeAlD
Argatroban—CYP3A5—Docetaxel—pancreatic cancer	0.0567	0.105	CbGbCtD
Argatroban—CYP3A5—Sunitinib—pancreatic cancer	0.0565	0.104	CbGbCtD
Argatroban—CYP3A4—Tamoxifen—pancreatic cancer	0.0393	0.0727	CbGbCtD
Argatroban—CYP3A4—Erlotinib—pancreatic cancer	0.0334	0.0618	CbGbCtD
Argatroban—CYP3A4—Irinotecan—pancreatic cancer	0.0302	0.0558	CbGbCtD
Argatroban—CYP3A4—Docetaxel—pancreatic cancer	0.0221	0.0409	CbGbCtD
Argatroban—CYP3A4—Sunitinib—pancreatic cancer	0.022	0.0407	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—pancreatic cancer	0.0165	0.0305	CbGbCtD
Argatroban—F2—gall bladder—pancreatic cancer	0.0103	0.0683	CbGeAlD
Argatroban—F2—digestive system—pancreatic cancer	0.00404	0.0269	CbGeAlD
Argatroban—CYP3A5—islet of Langerhans—pancreatic cancer	0.00272	0.0181	CbGeAlD
Argatroban—CYP3A5—pancreas—pancreatic cancer	0.00191	0.0127	CbGeAlD
Argatroban—CYP3A5—digestive system—pancreatic cancer	0.00163	0.0109	CbGeAlD
Argatroban—CYP3A4—digestive system—pancreatic cancer	0.00123	0.00816	CbGeAlD
Argatroban—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.000711	0.00278	CcSEcCtD
Argatroban—Chest pain—Tamoxifen—pancreatic cancer	0.00071	0.00278	CcSEcCtD
Argatroban—Renal impairment—Docetaxel—pancreatic cancer	0.00071	0.00277	CcSEcCtD
Argatroban—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000707	0.00276	CcSEcCtD
Argatroban—Dermatitis bullous—Docetaxel—pancreatic cancer	0.000707	0.00276	CcSEcCtD
Argatroban—Chest pain—Erlotinib—pancreatic cancer	0.000702	0.00275	CcSEcCtD
Argatroban—Urinary tract infection—Fluorouracil—pancreatic cancer	0.000701	0.00274	CcSEcCtD
Argatroban—Haematuria—Gemcitabine—pancreatic cancer	0.000699	0.00273	CcSEcCtD
Argatroban—Cardiac failure—Docetaxel—pancreatic cancer	0.000692	0.00271	CcSEcCtD
Argatroban—Back pain—Sunitinib—pancreatic cancer	0.000691	0.0027	CcSEcCtD
Argatroban—Bradycardia—Irinotecan—pancreatic cancer	0.000688	0.00269	CcSEcCtD
Argatroban—Haemoglobin—Irinotecan—pancreatic cancer	0.000679	0.00266	CcSEcCtD
Argatroban—Infection—Tamoxifen—pancreatic cancer	0.000676	0.00264	CcSEcCtD
Argatroban—Haemorrhage—Irinotecan—pancreatic cancer	0.000676	0.00264	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000675	0.00264	CcSEcCtD
Argatroban—Infection—Erlotinib—pancreatic cancer	0.000669	0.00262	CcSEcCtD
Argatroban—Haemoglobin—Gemcitabine—pancreatic cancer	0.000662	0.00259	CcSEcCtD
Argatroban—Vasodilation procedure—Doxorubicin—pancreatic cancer	0.000661	0.00258	CcSEcCtD
Argatroban—Vasodilation—Doxorubicin—pancreatic cancer	0.000661	0.00258	CcSEcCtD
Argatroban—Haemorrhage—Gemcitabine—pancreatic cancer	0.000658	0.00257	CcSEcCtD
Argatroban—Haemoglobin—Fluorouracil—pancreatic cancer	0.000651	0.00254	CcSEcCtD
Argatroban—Haemorrhage—Fluorouracil—pancreatic cancer	0.000647	0.00253	CcSEcCtD
Argatroban—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.000628	0.00245	CcSEcCtD
Argatroban—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000628	0.00245	CcSEcCtD
Argatroban—Cough—Sunitinib—pancreatic cancer	0.000623	0.00244	CcSEcCtD
Argatroban—Angiopathy—Irinotecan—pancreatic cancer	0.000613	0.0024	CcSEcCtD
Argatroban—Chest pain—Sunitinib—pancreatic cancer	0.000608	0.00238	CcSEcCtD
Argatroban—Dyspnoea—Tamoxifen—pancreatic cancer	0.000607	0.00237	CcSEcCtD
Argatroban—Dyspnoea—Erlotinib—pancreatic cancer	0.0006	0.00235	CcSEcCtD
Argatroban—Dyspepsia—Tamoxifen—pancreatic cancer	0.000599	0.00234	CcSEcCtD
Argatroban—Angiopathy—Gemcitabine—pancreatic cancer	0.000597	0.00234	CcSEcCtD
Argatroban—Dyspepsia—Erlotinib—pancreatic cancer	0.000593	0.00232	CcSEcCtD
Argatroban—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000588	0.0023	CcSEcCtD
Argatroban—Pain—Tamoxifen—pancreatic cancer	0.000582	0.00228	CcSEcCtD
Argatroban—Constipation—Tamoxifen—pancreatic cancer	0.000582	0.00228	CcSEcCtD
Argatroban—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000581	0.00227	CcSEcCtD
Argatroban—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.000581	0.00227	CcSEcCtD
Argatroban—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.000581	0.00227	CcSEcCtD
Argatroban—Infection—Sunitinib—pancreatic cancer	0.000579	0.00226	CcSEcCtD
Argatroban—Pain—Erlotinib—pancreatic cancer	0.000576	0.00225	CcSEcCtD
Argatroban—Constipation—Erlotinib—pancreatic cancer	0.000576	0.00225	CcSEcCtD
Argatroban—Back pain—Irinotecan—pancreatic cancer	0.000569	0.00223	CcSEcCtD
Argatroban—Angina pectoris—Docetaxel—pancreatic cancer	0.000569	0.00222	CcSEcCtD
Argatroban—Pulmonary oedema—Epirubicin—pancreatic cancer	0.000559	0.00218	CcSEcCtD
Argatroban—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000557	0.00218	CcSEcCtD
Argatroban—Back pain—Gemcitabine—pancreatic cancer	0.000554	0.00217	CcSEcCtD
Argatroban—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000551	0.00215	CcSEcCtD
Argatroban—Sepsis—Epirubicin—pancreatic cancer	0.000545	0.00213	CcSEcCtD
Argatroban—Abdominal pain—Tamoxifen—pancreatic cancer	0.000538	0.0021	CcSEcCtD
Argatroban—Abdominal pain—Erlotinib—pancreatic cancer	0.000532	0.00208	CcSEcCtD
Argatroban—Body temperature increased—Erlotinib—pancreatic cancer	0.000532	0.00208	CcSEcCtD
Argatroban—Thrombophlebitis—Epirubicin—pancreatic cancer	0.000526	0.00206	CcSEcCtD
Argatroban—Pneumonia—Docetaxel—pancreatic cancer	0.000523	0.00205	CcSEcCtD
Argatroban—Dyspnoea—Sunitinib—pancreatic cancer	0.00052	0.00203	CcSEcCtD
Argatroban—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000517	0.00202	CcSEcCtD
Argatroban—Cough—Irinotecan—pancreatic cancer	0.000513	0.00201	CcSEcCtD
Argatroban—Dyspepsia—Sunitinib—pancreatic cancer	0.000513	0.00201	CcSEcCtD
Argatroban—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000513	0.00201	CcSEcCtD
Argatroban—Myocardial infarction—Docetaxel—pancreatic cancer	0.00051	0.00199	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—pancreatic cancer	0.000504	0.00197	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000503	0.00197	CcSEcCtD
Argatroban—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000501	0.00196	CcSEcCtD
Argatroban—Cough—Gemcitabine—pancreatic cancer	0.0005	0.00196	CcSEcCtD
Argatroban—Pain—Sunitinib—pancreatic cancer	0.000498	0.00195	CcSEcCtD
Argatroban—Constipation—Sunitinib—pancreatic cancer	0.000498	0.00195	CcSEcCtD
Argatroban—Renal failure acute—Epirubicin—pancreatic cancer	0.000493	0.00193	CcSEcCtD
Argatroban—Chest pain—Gemcitabine—pancreatic cancer	0.000488	0.00191	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000487	0.0019	CcSEcCtD
Argatroban—Confusional state—Irinotecan—pancreatic cancer	0.000484	0.00189	CcSEcCtD
Argatroban—Chest pain—Fluorouracil—pancreatic cancer	0.00048	0.00188	CcSEcCtD
Argatroban—Renal impairment—Epirubicin—pancreatic cancer	0.000479	0.00187	CcSEcCtD
Argatroban—Infection—Irinotecan—pancreatic cancer	0.000477	0.00187	CcSEcCtD
Argatroban—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000477	0.00186	CcSEcCtD
Argatroban—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000477	0.00186	CcSEcCtD
Argatroban—Haemoglobin—Docetaxel—pancreatic cancer	0.00047	0.00184	CcSEcCtD
Argatroban—Haemorrhage—Docetaxel—pancreatic cancer	0.000467	0.00183	CcSEcCtD
Argatroban—Cardiac failure—Epirubicin—pancreatic cancer	0.000467	0.00183	CcSEcCtD
Argatroban—Diarrhoea—Tamoxifen—pancreatic cancer	0.000466	0.00182	CcSEcCtD
Argatroban—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000465	0.00182	CcSEcCtD
Argatroban—Infection—Gemcitabine—pancreatic cancer	0.000465	0.00182	CcSEcCtD
Argatroban—Confusional state—Fluorouracil—pancreatic cancer	0.000464	0.00181	CcSEcCtD
Argatroban—Body temperature increased—Sunitinib—pancreatic cancer	0.000461	0.0018	CcSEcCtD
Argatroban—Abdominal pain—Sunitinib—pancreatic cancer	0.000461	0.0018	CcSEcCtD
Argatroban—Diarrhoea—Erlotinib—pancreatic cancer	0.000461	0.0018	CcSEcCtD
Argatroban—Infection—Fluorouracil—pancreatic cancer	0.000457	0.00179	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—pancreatic cancer	0.000456	0.00179	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000455	0.00178	CcSEcCtD
Argatroban—Dizziness—Tamoxifen—pancreatic cancer	0.00045	0.00176	CcSEcCtD
Argatroban—Tachycardia—Fluorouracil—pancreatic cancer	0.000449	0.00176	CcSEcCtD
Argatroban—Hypotension—Irinotecan—pancreatic cancer	0.000449	0.00175	CcSEcCtD
Argatroban—Dizziness—Erlotinib—pancreatic cancer	0.000445	0.00174	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—pancreatic cancer	0.000443	0.00173	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000441	0.00172	CcSEcCtD
Argatroban—Hypotension—Gemcitabine—pancreatic cancer	0.000437	0.00171	CcSEcCtD
Argatroban—Cardiac arrest—Epirubicin—pancreatic cancer	0.000433	0.00169	CcSEcCtD
Argatroban—Vomiting—Tamoxifen—pancreatic cancer	0.000433	0.00169	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—pancreatic cancer	0.000432	0.00169	CcSEcCtD
Argatroban—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.00043	0.00168	CcSEcCtD
Argatroban—Hypotension—Fluorouracil—pancreatic cancer	0.00043	0.00168	CcSEcCtD
Argatroban—Hypersensitivity—Sunitinib—pancreatic cancer	0.000429	0.00168	CcSEcCtD
Argatroban—Rash—Tamoxifen—pancreatic cancer	0.000429	0.00168	CcSEcCtD
Argatroban—Dermatitis—Tamoxifen—pancreatic cancer	0.000429	0.00168	CcSEcCtD
Argatroban—Vomiting—Erlotinib—pancreatic cancer	0.000428	0.00167	CcSEcCtD
Argatroban—Dyspnoea—Irinotecan—pancreatic cancer	0.000428	0.00167	CcSEcCtD
Argatroban—Headache—Tamoxifen—pancreatic cancer	0.000426	0.00167	CcSEcCtD
Argatroban—Rash—Erlotinib—pancreatic cancer	0.000425	0.00166	CcSEcCtD
Argatroban—Dermatitis—Erlotinib—pancreatic cancer	0.000424	0.00166	CcSEcCtD
Argatroban—Angiopathy—Docetaxel—pancreatic cancer	0.000424	0.00166	CcSEcCtD
Argatroban—Dyspepsia—Irinotecan—pancreatic cancer	0.000423	0.00165	CcSEcCtD
Argatroban—Headache—Erlotinib—pancreatic cancer	0.000422	0.00165	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000421	0.00165	CcSEcCtD
Argatroban—Dyspnoea—Gemcitabine—pancreatic cancer	0.000417	0.00163	CcSEcCtD
Argatroban—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000415	0.00162	CcSEcCtD
Argatroban—Constipation—Irinotecan—pancreatic cancer	0.000411	0.00161	CcSEcCtD
Argatroban—Pain—Irinotecan—pancreatic cancer	0.000411	0.00161	CcSEcCtD
Argatroban—Dyspnoea—Fluorouracil—pancreatic cancer	0.00041	0.0016	CcSEcCtD
Argatroban—Dyspepsia—Fluorouracil—pancreatic cancer	0.000405	0.00158	CcSEcCtD
Argatroban—Nausea—Tamoxifen—pancreatic cancer	0.000404	0.00158	CcSEcCtD
Argatroban—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000404	0.00158	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000401	0.00157	CcSEcCtD
Argatroban—Pain—Gemcitabine—pancreatic cancer	0.0004	0.00156	CcSEcCtD
Argatroban—Constipation—Gemcitabine—pancreatic cancer	0.0004	0.00156	CcSEcCtD
Argatroban—Nausea—Erlotinib—pancreatic cancer	0.0004	0.00156	CcSEcCtD
Argatroban—Diarrhoea—Sunitinib—pancreatic cancer	0.000399	0.00156	CcSEcCtD
Argatroban—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000397	0.00155	CcSEcCtD
Argatroban—Feeling abnormal—Irinotecan—pancreatic cancer	0.000396	0.00155	CcSEcCtD
Argatroban—Back pain—Docetaxel—pancreatic cancer	0.000393	0.00154	CcSEcCtD
Argatroban—Pain—Fluorouracil—pancreatic cancer	0.000393	0.00154	CcSEcCtD
Argatroban—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000393	0.00154	CcSEcCtD
Argatroban—Dizziness—Sunitinib—pancreatic cancer	0.000385	0.00151	CcSEcCtD
Argatroban—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000385	0.00151	CcSEcCtD
Argatroban—Angina pectoris—Epirubicin—pancreatic cancer	0.000383	0.0015	CcSEcCtD
Argatroban—Body temperature increased—Irinotecan—pancreatic cancer	0.00038	0.00148	CcSEcCtD
Argatroban—Abdominal pain—Irinotecan—pancreatic cancer	0.00038	0.00148	CcSEcCtD
Argatroban—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000379	0.00148	CcSEcCtD
Argatroban—Vomiting—Sunitinib—pancreatic cancer	0.000371	0.00145	CcSEcCtD
Argatroban—Body temperature increased—Gemcitabine—pancreatic cancer	0.00037	0.00145	CcSEcCtD
Argatroban—Rash—Sunitinib—pancreatic cancer	0.000368	0.00144	CcSEcCtD
Argatroban—Dermatitis—Sunitinib—pancreatic cancer	0.000367	0.00144	CcSEcCtD
Argatroban—Headache—Sunitinib—pancreatic cancer	0.000365	0.00143	CcSEcCtD
Argatroban—Body temperature increased—Fluorouracil—pancreatic cancer	0.000364	0.00142	CcSEcCtD
Argatroban—Cough—Docetaxel—pancreatic cancer	0.000355	0.00139	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—pancreatic cancer	0.000355	0.00139	CcSEcCtD
Argatroban—Hypersensitivity—Irinotecan—pancreatic cancer	0.000354	0.00138	CcSEcCtD
Argatroban—Pneumonia—Epirubicin—pancreatic cancer	0.000353	0.00138	CcSEcCtD
Argatroban—Chest pain—Docetaxel—pancreatic cancer	0.000346	0.00135	CcSEcCtD
Argatroban—Nausea—Sunitinib—pancreatic cancer	0.000346	0.00135	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—pancreatic cancer	0.000341	0.00133	CcSEcCtD
Argatroban—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000339	0.00132	CcSEcCtD
Argatroban—Haematuria—Epirubicin—pancreatic cancer	0.000335	0.00131	CcSEcCtD
Argatroban—Confusional state—Docetaxel—pancreatic cancer	0.000335	0.00131	CcSEcCtD
Argatroban—Infection—Docetaxel—pancreatic cancer	0.00033	0.00129	CcSEcCtD
Argatroban—Diarrhoea—Irinotecan—pancreatic cancer	0.000329	0.00128	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—pancreatic cancer	0.000327	0.00128	CcSEcCtD
Argatroban—Tachycardia—Docetaxel—pancreatic cancer	0.000324	0.00127	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—pancreatic cancer	0.000321	0.00125	CcSEcCtD
Argatroban—Diarrhoea—Gemcitabine—pancreatic cancer	0.00032	0.00125	CcSEcCtD
Argatroban—Dizziness—Irinotecan—pancreatic cancer	0.000318	0.00124	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—pancreatic cancer	0.000317	0.00124	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000316	0.00123	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—pancreatic cancer	0.000315	0.00123	CcSEcCtD
Argatroban—Diarrhoea—Fluorouracil—pancreatic cancer	0.000315	0.00123	CcSEcCtD
Argatroban—Hypotension—Docetaxel—pancreatic cancer	0.00031	0.00121	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—pancreatic cancer	0.00031	0.00121	CcSEcCtD
Argatroban—Vomiting—Irinotecan—pancreatic cancer	0.000305	0.00119	CcSEcCtD
Argatroban—Dizziness—Fluorouracil—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Argatroban—Rash—Irinotecan—pancreatic cancer	0.000303	0.00118	CcSEcCtD
Argatroban—Dermatitis—Irinotecan—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Argatroban—Headache—Irinotecan—pancreatic cancer	0.000301	0.00118	CcSEcCtD
Argatroban—Vomiting—Gemcitabine—pancreatic cancer	0.000297	0.00116	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—pancreatic cancer	0.000297	0.00116	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.000296	0.00555	CbGpPWpGaD
Argatroban—Dyspnoea—Docetaxel—pancreatic cancer	0.000296	0.00116	CcSEcCtD
Argatroban—F2—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.000295	0.00554	CbGpPWpGaD
Argatroban—Rash—Gemcitabine—pancreatic cancer	0.000295	0.00115	CcSEcCtD
Argatroban—Dermatitis—Gemcitabine—pancreatic cancer	0.000295	0.00115	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—pancreatic cancer	0.000293	0.00115	CcSEcCtD
Argatroban—Headache—Gemcitabine—pancreatic cancer	0.000293	0.00115	CcSEcCtD
Argatroban—Vomiting—Fluorouracil—pancreatic cancer	0.000292	0.00114	CcSEcCtD
Argatroban—Dyspepsia—Docetaxel—pancreatic cancer	0.000292	0.00114	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—AGTR1—pancreatic cancer	0.000292	0.00547	CbGpPWpGaD
Argatroban—Haemorrhage—Doxorubicin—pancreatic cancer	0.000292	0.00114	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000291	0.00546	CbGpPWpGaD
Argatroban—Rash—Fluorouracil—pancreatic cancer	0.00029	0.00113	CcSEcCtD
Argatroban—Dermatitis—Fluorouracil—pancreatic cancer	0.00029	0.00113	CcSEcCtD
Argatroban—Headache—Fluorouracil—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Argatroban—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000287	0.00112	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—pancreatic cancer	0.000286	0.00112	CcSEcCtD
Argatroban—Nausea—Irinotecan—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Argatroban—Pain—Docetaxel—pancreatic cancer	0.000284	0.00111	CcSEcCtD
Argatroban—Constipation—Docetaxel—pancreatic cancer	0.000284	0.00111	CcSEcCtD
Argatroban—F2—PAR1-mediated thrombin signaling events—PIK3CA—pancreatic cancer	0.000278	0.00522	CbGpPWpGaD
Argatroban—Nausea—Gemcitabine—pancreatic cancer	0.000278	0.00109	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.000277	0.00519	CbGpPWpGaD
Argatroban—Feeling abnormal—Docetaxel—pancreatic cancer	0.000274	0.00107	CcSEcCtD
Argatroban—Nausea—Fluorouracil—pancreatic cancer	0.000273	0.00107	CcSEcCtD
Argatroban—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000271	0.00106	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—pancreatic cancer	0.000271	0.00507	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.000266	0.00499	CbGpPWpGaD
Argatroban—Back pain—Epirubicin—pancreatic cancer	0.000265	0.00104	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—pancreatic cancer	0.000265	0.00103	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.000264	0.00495	CbGpPWpGaD
Argatroban—Body temperature increased—Docetaxel—pancreatic cancer	0.000262	0.00103	CcSEcCtD
Argatroban—Abdominal pain—Docetaxel—pancreatic cancer	0.000262	0.00103	CcSEcCtD
Argatroban—F2—Hemostasis—IFNA5—pancreatic cancer	0.000258	0.00483	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—AKT1—pancreatic cancer	0.000256	0.00481	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000255	0.00478	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—pancreatic cancer	0.000247	0.00462	CbGpPWpGaD
Argatroban—Back pain—Doxorubicin—pancreatic cancer	0.000246	0.00096	CcSEcCtD
Argatroban—Hypersensitivity—Docetaxel—pancreatic cancer	0.000245	0.000956	CcSEcCtD
Argatroban—F2—Hemostasis—PPP2R5B—pancreatic cancer	0.000243	0.00456	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—SCT—pancreatic cancer	0.000242	0.00454	CbGpPWpGaD
Argatroban—Cough—Epirubicin—pancreatic cancer	0.000239	0.000936	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CB—pancreatic cancer	0.000234	0.00439	CbGpPWpGaD
Argatroban—Chest pain—Epirubicin—pancreatic cancer	0.000234	0.000913	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCK—pancreatic cancer	0.000231	0.00433	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00023	0.00431	CbGpPWpGaD
Argatroban—Diarrhoea—Docetaxel—pancreatic cancer	0.000227	0.000888	CcSEcCtD
Argatroban—Confusional state—Epirubicin—pancreatic cancer	0.000226	0.000883	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CNR2—pancreatic cancer	0.000225	0.00422	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GLP1R—pancreatic cancer	0.000225	0.00422	CbGpPWpGaD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000223	0.00418	CbGpPWpGaD
Argatroban—Infection—Epirubicin—pancreatic cancer	0.000222	0.00087	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCKAR—pancreatic cancer	0.000222	0.00416	CbGpPWpGaD
Argatroban—Cough—Doxorubicin—pancreatic cancer	0.000221	0.000866	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	0.000221	0.00413	CbGpPWpGaD
Argatroban—Dizziness—Docetaxel—pancreatic cancer	0.000219	0.000858	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—pancreatic cancer	0.000218	0.000854	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	0.000218	0.00409	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—pancreatic cancer	0.000217	0.00406	CbGpPWpGaD
Argatroban—Chest pain—Doxorubicin—pancreatic cancer	0.000216	0.000845	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000212	0.00398	CbGpPWpGaD
Argatroban—Vomiting—Docetaxel—pancreatic cancer	0.000211	0.000825	CcSEcCtD
Argatroban—Rash—Docetaxel—pancreatic cancer	0.000209	0.000818	CcSEcCtD
Argatroban—Hypotension—Epirubicin—pancreatic cancer	0.000209	0.000818	CcSEcCtD
Argatroban—F2—Metabolism of proteins—PCSK1—pancreatic cancer	0.000209	0.00392	CbGpPWpGaD
Argatroban—Dermatitis—Docetaxel—pancreatic cancer	0.000209	0.000818	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—pancreatic cancer	0.000209	0.000817	CcSEcCtD
Argatroban—Headache—Docetaxel—pancreatic cancer	0.000208	0.000813	CcSEcCtD
Argatroban—Infection—Doxorubicin—pancreatic cancer	0.000206	0.000805	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—pancreatic cancer	0.000202	0.000791	CcSEcCtD
Argatroban—F2—GPCR ligand binding—SHH—pancreatic cancer	0.000202	0.00379	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—pancreatic cancer	0.000202	0.00378	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRLHR—pancreatic cancer	0.000201	0.00377	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—IAPP—pancreatic cancer	0.0002	0.00374	CbGpPWpGaD
Argatroban—Dyspnoea—Epirubicin—pancreatic cancer	0.0002	0.00078	CcSEcCtD
Argatroban—Nausea—Docetaxel—pancreatic cancer	0.000197	0.000771	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—pancreatic cancer	0.000197	0.000771	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000196	0.00367	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	0.000194	0.00363	CbGpPWpGaD
Argatroban—Hypotension—Doxorubicin—pancreatic cancer	0.000194	0.000757	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000193	0.000756	CcSEcCtD
Argatroban—F2—GPCR ligand binding—PTHLH—pancreatic cancer	0.000192	0.00359	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTCH1—pancreatic cancer	0.000192	0.00359	CbGpPWpGaD
Argatroban—Pain—Epirubicin—pancreatic cancer	0.000191	0.000749	CcSEcCtD
Argatroban—Constipation—Epirubicin—pancreatic cancer	0.000191	0.000749	CcSEcCtD
Argatroban—F2—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000191	0.00359	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—pancreatic cancer	0.000191	0.00358	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000189	0.00353	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—SRC—pancreatic cancer	0.000188	0.00352	CbGpPWpGaD
Argatroban—Dyspnoea—Doxorubicin—pancreatic cancer	0.000185	0.000722	CcSEcCtD
Argatroban—F2—Signaling Pathways—GDI2—pancreatic cancer	0.000185	0.00346	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GDI1—pancreatic cancer	0.000185	0.00346	CbGpPWpGaD
Argatroban—Feeling abnormal—Epirubicin—pancreatic cancer	0.000184	0.000721	CcSEcCtD
Argatroban—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000183	0.000716	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—pancreatic cancer	0.000182	0.000713	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000181	0.00339	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—NRAS—pancreatic cancer	0.000181	0.00339	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000179	0.000699	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—PPY—pancreatic cancer	0.000177	0.00332	CbGpPWpGaD
Argatroban—Constipation—Doxorubicin—pancreatic cancer	0.000177	0.000693	CcSEcCtD
Argatroban—Pain—Doxorubicin—pancreatic cancer	0.000177	0.000693	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—pancreatic cancer	0.000177	0.000692	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—pancreatic cancer	0.000177	0.000692	CcSEcCtD
Argatroban—F2—GPCR ligand binding—SST—pancreatic cancer	0.000175	0.00328	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000174	0.00326	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000172	0.00323	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000171	0.00321	CbGpPWpGaD
Argatroban—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000171	0.000668	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000169	0.000662	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	0.000169	0.00317	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000168	0.00315	CbGpPWpGaD
Argatroban—Hypersensitivity—Epirubicin—pancreatic cancer	0.000165	0.000645	CcSEcCtD
Argatroban—F2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000164	0.00308	CbGpPWpGaD
Argatroban—Body temperature increased—Doxorubicin—pancreatic cancer	0.000164	0.00064	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—pancreatic cancer	0.000164	0.00064	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CNR1—pancreatic cancer	0.000162	0.00303	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PPY—pancreatic cancer	0.000161	0.00302	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000161	0.00301	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000159	0.00298	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000158	0.00296	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GCG—pancreatic cancer	0.000156	0.00293	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—KRAS—pancreatic cancer	0.000155	0.00291	CbGpPWpGaD
Argatroban—Diarrhoea—Epirubicin—pancreatic cancer	0.000153	0.000599	CcSEcCtD
Argatroban—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000153	0.000597	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000153	0.00286	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000149	0.00279	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000149	0.00279	CbGpPWpGaD
Argatroban—Dizziness—Epirubicin—pancreatic cancer	0.000148	0.000579	CcSEcCtD
Argatroban—F2—Hemostasis—CD44—pancreatic cancer	0.000146	0.00273	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GAST—pancreatic cancer	0.000145	0.00271	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—pancreatic cancer	0.000143	0.00268	CbGpPWpGaD
Argatroban—Vomiting—Epirubicin—pancreatic cancer	0.000142	0.000557	CcSEcCtD
Argatroban—Diarrhoea—Doxorubicin—pancreatic cancer	0.000142	0.000554	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.000141	0.00265	CbGpPWpGaD
Argatroban—Rash—Epirubicin—pancreatic cancer	0.000141	0.000552	CcSEcCtD
Argatroban—F2—Hemostasis—IFNA1—pancreatic cancer	0.000141	0.00264	CbGpPWpGaD
Argatroban—Dermatitis—Epirubicin—pancreatic cancer	0.000141	0.000551	CcSEcCtD
Argatroban—Headache—Epirubicin—pancreatic cancer	0.00014	0.000548	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—SCT—pancreatic cancer	0.000137	0.00257	CbGpPWpGaD
Argatroban—Dizziness—Doxorubicin—pancreatic cancer	0.000137	0.000536	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.000134	0.00251	CbGpPWpGaD
Argatroban—Nausea—Epirubicin—pancreatic cancer	0.000133	0.00052	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—HRAS—pancreatic cancer	0.000132	0.00248	CbGpPWpGaD
Argatroban—Vomiting—Doxorubicin—pancreatic cancer	0.000132	0.000515	CcSEcCtD
Argatroban—F2—Hemostasis—IFNA2—pancreatic cancer	0.000131	0.00246	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GAST—pancreatic cancer	0.000131	0.00246	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCK—pancreatic cancer	0.000131	0.00245	CbGpPWpGaD
Argatroban—Rash—Doxorubicin—pancreatic cancer	0.000131	0.000511	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—pancreatic cancer	0.00013	0.00051	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.00013	0.00244	CbGpPWpGaD
Argatroban—Headache—Doxorubicin—pancreatic cancer	0.00013	0.000507	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000127	0.00239	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000127	0.00239	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000125	0.00235	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SCT—pancreatic cancer	0.000124	0.00233	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.000123	0.00231	CbGpPWpGaD
Argatroban—Nausea—Doxorubicin—pancreatic cancer	0.000123	0.000481	CcSEcCtD
Argatroban—F2—Signaling Pathways—PRLHR—pancreatic cancer	0.000119	0.00223	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCK—pancreatic cancer	0.000119	0.00222	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000119	0.00222	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CNR2—pancreatic cancer	0.000116	0.00217	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000116	0.00217	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000114	0.00213	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000113	0.00211	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.000112	0.0021	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000112	0.0021	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000112	0.0021	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—GCG—pancreatic cancer	0.00011	0.00206	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000108	0.00203	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SHH—pancreatic cancer	0.000104	0.00194	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000103	0.00193	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IAPP—pancreatic cancer	0.000102	0.00192	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SSTR3—pancreatic cancer	0.000101	0.0019	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DTX1—pancreatic cancer	0.000101	0.0019	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—SST—pancreatic cancer	9.9e-05	0.00186	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	9.88e-05	0.00185	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTHLH—pancreatic cancer	9.83e-05	0.00184	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTCH1—pancreatic cancer	9.83e-05	0.00184	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	9.71e-05	0.00182	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SSTR1—pancreatic cancer	9.7e-05	0.00182	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	9.62e-05	0.0018	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPY—pancreatic cancer	9.51e-05	0.00178	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SSTR2—pancreatic cancer	9.33e-05	0.00175	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLAU—pancreatic cancer	9.32e-05	0.00175	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CNR1—pancreatic cancer	9.14e-05	0.00171	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCKBR—pancreatic cancer	9.02e-05	0.00169	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SST—pancreatic cancer	8.99e-05	0.00169	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	8.97e-05	0.00168	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	8.85e-05	0.00166	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	8.83e-05	0.00165	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GCG—pancreatic cancer	8.83e-05	0.00165	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—pancreatic cancer	8.59e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GLI1—pancreatic cancer	8.48e-05	0.00159	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DTX4—pancreatic cancer	8.48e-05	0.00159	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AGTR1—pancreatic cancer	8.42e-05	0.00158	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	8.36e-05	0.00157	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CNR1—pancreatic cancer	8.3e-05	0.00156	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—pancreatic cancer	8.29e-05	0.00155	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP2R5B—pancreatic cancer	8.25e-05	0.00155	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NRP1—pancreatic cancer	8.25e-05	0.00155	CbGpPWpGaD
Argatroban—F2—Hemostasis—EGF—pancreatic cancer	8.2e-05	0.00154	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GCG—pancreatic cancer	8.02e-05	0.0015	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEY2—pancreatic cancer	7.94e-05	0.00149	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GAST—pancreatic cancer	7.75e-05	0.00145	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	7.68e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AGTR1—pancreatic cancer	7.65e-05	0.00143	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	7.51e-05	0.00141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SCT—pancreatic cancer	7.35e-05	0.00138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEY1—pancreatic cancer	7.35e-05	0.00138	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CD—pancreatic cancer	7.29e-05	0.00137	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	7.11e-05	0.00133	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCK—pancreatic cancer	7.01e-05	0.00131	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CNR2—pancreatic cancer	6.83e-05	0.00128	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GLP1R—pancreatic cancer	6.83e-05	0.00128	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—pancreatic cancer	6.83e-05	0.00128	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCKAR—pancreatic cancer	6.72e-05	0.00126	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAG2—pancreatic cancer	6.52e-05	0.00122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MEN1—pancreatic cancer	6.42e-05	0.0012	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—pancreatic cancer	6.35e-05	0.00119	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PRSS1—pancreatic cancer	6.16e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.14e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SHH—pancreatic cancer	6.13e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH4—pancreatic cancer	6.09e-05	0.00114	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IAPP—pancreatic cancer	6.05e-05	0.00113	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTHLH—pancreatic cancer	5.81e-05	0.00109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTCH1—pancreatic cancer	5.81e-05	0.00109	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—pancreatic cancer	5.78e-05	0.00108	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ARG2—pancreatic cancer	5.34e-05	0.001	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SST—pancreatic cancer	5.31e-05	0.000996	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.24e-05	0.000982	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAG1—pancreatic cancer	5.2e-05	0.000974	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH3—pancreatic cancer	5.18e-05	0.00097	CbGpPWpGaD
Argatroban—F2—Hemostasis—SRC—pancreatic cancer	5.09e-05	0.000954	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—pancreatic cancer	4.96e-05	0.000929	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CNR1—pancreatic cancer	4.9e-05	0.000919	CbGpPWpGaD
Argatroban—F2—Hemostasis—NRAS—pancreatic cancer	4.9e-05	0.000918	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—pancreatic cancer	4.8e-05	0.0009	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—pancreatic cancer	4.76e-05	0.000892	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GCG—pancreatic cancer	4.74e-05	0.000888	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TYMP—pancreatic cancer	4.67e-05	0.000875	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.61e-05	0.000863	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—pancreatic cancer	4.55e-05	0.000853	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGTR1—pancreatic cancer	4.52e-05	0.000847	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STK11—pancreatic cancer	4.45e-05	0.000834	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—pancreatic cancer	4.43e-05	0.00083	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—pancreatic cancer	4.22e-05	0.00079	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.18e-05	0.000784	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.02e-05	0.000753	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SMAD4—pancreatic cancer	3.9e-05	0.000731	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—pancreatic cancer	3.87e-05	0.000726	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—pancreatic cancer	3.86e-05	0.000723	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HES1—pancreatic cancer	3.81e-05	0.000714	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GLP1R—pancreatic cancer	3.76e-05	0.000706	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—pancreatic cancer	3.75e-05	0.000702	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DPYD—pancreatic cancer	3.7e-05	0.000694	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—pancreatic cancer	3.65e-05	0.000683	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—pancreatic cancer	3.58e-05	0.000672	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	3.51e-05	0.000659	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—pancreatic cancer	3.5e-05	0.000657	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—pancreatic cancer	3.34e-05	0.000625	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—pancreatic cancer	3.19e-05	0.000598	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TSC2—pancreatic cancer	3.18e-05	0.000597	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—pancreatic cancer	3.16e-05	0.000593	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—pancreatic cancer	3.11e-05	0.000584	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—pancreatic cancer	3.05e-05	0.000572	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKBIA—pancreatic cancer	2.9e-05	0.000544	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH1—pancreatic cancer	2.87e-05	0.000539	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.86e-05	0.000537	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—pancreatic cancer	2.81e-05	0.000527	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NRAS—pancreatic cancer	2.81e-05	0.000527	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGF—pancreatic cancer	2.78e-05	0.000521	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD44—pancreatic cancer	2.72e-05	0.00051	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCG—pancreatic cancer	2.61e-05	0.000489	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—pancreatic cancer	2.56e-05	0.00048	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.48e-05	0.000466	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—pancreatic cancer	2.47e-05	0.000463	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—STK11—pancreatic cancer	2.45e-05	0.00046	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.45e-05	0.000459	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—pancreatic cancer	2.42e-05	0.000453	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.22e-05	0.000417	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.17e-05	0.000407	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—pancreatic cancer	2.15e-05	0.000404	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TYMS—pancreatic cancer	2.11e-05	0.000396	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—pancreatic cancer	2.07e-05	0.000388	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—pancreatic cancer	2.06e-05	0.000385	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—pancreatic cancer	2e-05	0.000375	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—pancreatic cancer	1.98e-05	0.000371	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—pancreatic cancer	1.93e-05	0.000361	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—pancreatic cancer	1.91e-05	0.000358	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—pancreatic cancer	1.87e-05	0.000351	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—pancreatic cancer	1.86e-05	0.000349	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—pancreatic cancer	1.82e-05	0.00034	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.75e-05	0.000328	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SRC—pancreatic cancer	1.73e-05	0.000324	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.72e-05	0.000323	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—pancreatic cancer	1.72e-05	0.000322	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—pancreatic cancer	1.68e-05	0.000315	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—pancreatic cancer	1.66e-05	0.000312	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NRAS—pancreatic cancer	1.66e-05	0.000311	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.63e-05	0.000306	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.55e-05	0.00029	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—pancreatic cancer	1.55e-05	0.00029	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—pancreatic cancer	1.54e-05	0.000289	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—pancreatic cancer	1.51e-05	0.000284	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.49e-05	0.00028	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—pancreatic cancer	1.43e-05	0.000268	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.36e-05	0.000255	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—pancreatic cancer	1.31e-05	0.000246	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—pancreatic cancer	1.27e-05	0.000238	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD44—pancreatic cancer	1.27e-05	0.000237	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—pancreatic cancer	1.21e-05	0.000228	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCG—pancreatic cancer	1.21e-05	0.000227	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.19e-05	0.000222	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.18e-05	0.00022	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—STK11—pancreatic cancer	1.14e-05	0.000214	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—pancreatic cancer	1.07e-05	0.000201	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—pancreatic cancer	1.03e-05	0.000192	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TYMS—pancreatic cancer	9.81e-06	0.000184	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—pancreatic cancer	7.98e-06	0.00015	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	7.24e-06	0.000136	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.2e-06	0.000135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.95e-06	0.00013	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.33e-06	0.000119	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—pancreatic cancer	5.91e-06	0.000111	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.52e-06	0.000103	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.47e-06	0.000102	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.77e-06	8.94e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.36e-06	6.3e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.75e-06	5.15e-05	CbGpPWpGaD
